Jiwon Koh

1.6k total citations
73 papers, 1.0k citations indexed

About

Jiwon Koh is a scholar working on Oncology, Pathology and Forensic Medicine and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Jiwon Koh has authored 73 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Oncology, 22 papers in Pathology and Forensic Medicine and 21 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Jiwon Koh's work include Cancer Immunotherapy and Biomarkers (14 papers), Lymphoma Diagnosis and Treatment (13 papers) and Cancer Genomics and Diagnostics (9 papers). Jiwon Koh is often cited by papers focused on Cancer Immunotherapy and Biomarkers (14 papers), Lymphoma Diagnosis and Treatment (13 papers) and Cancer Genomics and Diagnostics (9 papers). Jiwon Koh collaborates with scholars based in South Korea, United States and Ethiopia. Jiwon Koh's co-authors include Hye Seung Lee, Yoonjin Kwak, Woo Ho Kim, Hyung‐Ho Kim, Do Joong Park, Yoon Kyung Jeon, Soo Kyung Nam, Sung‐Bum Kang, Yujun Park and Sang-Hoon Ahn and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Nature reviews. Cancer.

In The Last Decade

Jiwon Koh

63 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jiwon Koh South Korea 18 663 364 216 199 198 73 1.0k
Albiruni Ryan Abdul Razak Canada 18 661 1.0× 375 1.0× 125 0.6× 185 0.9× 94 0.5× 100 1.3k
Chan-Young Ock South Korea 21 1.0k 1.5× 508 1.4× 140 0.6× 255 1.3× 286 1.4× 42 1.4k
Ji‐Young Choe South Korea 19 699 1.1× 585 1.6× 252 1.2× 238 1.2× 99 0.5× 54 1.2k
Maria Raffaella Ambrosio Italy 18 392 0.6× 178 0.5× 272 1.3× 221 1.1× 85 0.4× 79 962
Judith Raimbourg France 10 677 1.0× 377 1.0× 118 0.5× 116 0.6× 127 0.6× 53 982
Federico Buffoli Italy 19 478 0.7× 532 1.5× 288 1.3× 115 0.6× 151 0.8× 45 1.2k
Takamitsu Kanazawa Japan 21 711 1.1× 268 0.7× 336 1.6× 147 0.7× 58 0.3× 45 1.2k
Roman Groisberg United States 14 442 0.7× 385 1.1× 96 0.4× 167 0.8× 117 0.6× 50 742
Xinyu Bi China 17 480 0.7× 289 0.8× 110 0.5× 245 1.2× 80 0.4× 100 1.2k

Countries citing papers authored by Jiwon Koh

Since Specialization
Citations

This map shows the geographic impact of Jiwon Koh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiwon Koh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiwon Koh more than expected).

Fields of papers citing papers by Jiwon Koh

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jiwon Koh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiwon Koh. The network helps show where Jiwon Koh may publish in the future.

Co-authorship network of co-authors of Jiwon Koh

This figure shows the co-authorship network connecting the top 25 collaborators of Jiwon Koh. A scholar is included among the top collaborators of Jiwon Koh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jiwon Koh. Jiwon Koh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Koh, Jiwon & Seock‐Ah Im. (2025). Redefining HER2 in Breast Cancer: From Conventional Positivity to Low and Ultralow in the New Era of Antibody-Drug Conjugates. Cancer Research and Treatment. 58(1). 15–25.
2.
Seo, Jieun, Jiwon Koh, Seock‐Ah Im, et al.. (2025). Cancer Manipulates Adjacent Adipose Tissue to Exploit Fatty Acids via HIF‐1α/CCL2/PPARα Axis: A Metabolic Circuit to Support Tumor Progression. Advanced Science. 13(3). e15186–e15186.
3.
Kim, So Hyeon, Young Joo Park, Ahrum Min, et al.. (2025). DNA damage and Nuclear Anaplasia Induced by Trastuzumab Deruxtecan in Cancer Cells with Variable HER2 Expression and Homologous Recombination Deficiency Status. Cancer Research and Treatment. 1 indexed citations
4.
Lim, Yoojoo, Chan‐Young Ock, Jeonghwan Youk, et al.. (2025). Predictive role of tumor-infiltrating lymphocytes and immune phenotype for pembrolizumab in relapsed or refractory thymic carcinoma. Journal of Thoracic Disease. 17(7). 4409–4419.
5.
Kang, Eunhye, Jeeyeon Lee, Jiwon Koh, et al.. (2024). Prognostic Performance of the Next-Generation Sequencing-Based Multigene Assay in Early Breast Cancer Patients Treated According to the 21-Gene Assay Results. Cancer Research and Treatment. 57(3). 749–759.
6.
Koh, Jiwon, Jaemoon Koh, Yoon Kyung Jeon, et al.. (2024). Fetal Lung Interstitial Tumor: A Comprehensive Case Study with an Emphasis on Next-Generation Sequencing. SHILAP Revista de lepidopterología. 57(4). 408–412. 1 indexed citations
7.
Yim, Jeemin, Jiwon Koh, Sehui Kim, et al.. (2024). Clinicopathological implications of immunohistochemical expression of TBX21, CXCR3, GATA3, CCR4, and TCF1 in nodal follicular helper T-cell lymphoma and peripheral T-cell lymphoma, not otherwise specified. Journal of Pathology and Translational Medicine. 58(2). 59–71. 2 indexed citations
8.
Ryu, Han Suk, Ilias P. Nikas, Jiwon Koh, et al.. (2024). Immune marker expression and prognosis of early breast cancer expressing HER3. European Journal of Cancer. 213. 115081–115081. 4 indexed citations
9.
Koh, Jiwon, Jeong Mo Bae, Hongseok Yun, et al.. (2024). Transformation of t(14;18)-negative follicular lymphoma to plasmablastic lymphoma: a case report with analysis of genetic evolution. Diagnostic Pathology. 19(1). 86–86. 3 indexed citations
10.
Koh, Jiwon, Hyun Keun Chee, Kyung‐Hee Kim, et al.. (2023). Historical Review and Future of Cardiac Xenotransplantation. Korean Circulation Journal. 53(6). 351–351. 2 indexed citations
11.
12.
Koh, Jiwon, Chul Lee, Hee Jeong, et al.. (2021). Genetic profiles of subcutaneous panniculitis-like T-cell lymphoma and clinicopathological impact of HAVCR2 mutations. Blood Advances. 5(20). 3919–3930. 33 indexed citations
13.
14.
Hwang, Eun Hye, Hyebin Lee, Hyeon Jeong Oh, et al.. (2020). Tryptophanyl-tRNA Synthetase Sensitizes Hormone Receptor-Positive Breast Cancer to Docetaxel-Based Chemotherapy. Journal of Breast Cancer. 23(6). 599–599. 6 indexed citations
15.
Kwon, Young Nam, Jiwon Koh, Yoon Kyung Jeon, et al.. (2020). A case of MOG encephalomyelitis with T- cell lymphoma. Multiple Sclerosis and Related Disorders. 41. 102038–102038. 6 indexed citations
16.
Yun, Sumi, Jiwon Koh, Soo Kyung Nam, et al.. (2020). Immunoscore is a strong predictor of survival in the prognosis of stage II/III gastric cancer patients following 5-FU-based adjuvant chemotherapy. Cancer Immunology Immunotherapy. 70(2). 431–441. 14 indexed citations
17.
Koh, Jiwon, Soo Kyung Nam, Youn Woo Lee, et al.. (2019). Trastuzumab Specific Epitope Evaluation as a Predictive and Prognostic Biomarker in Gastric Cancer Patients. Biomolecules. 9(12). 782–782. 3 indexed citations
18.
Koh, Jiwon, et al.. (2018). Gastric inverted hyperplastic polyp with inflammatory myofibroblastic tumor-like stroma, mimicking GI stromal tumor. Gastrointestinal Endoscopy. 89(2). 433–435. 5 indexed citations
19.
Lee, Hye Seung, Woo Ho Kim, Yoonjin Kwak, et al.. (2017). Molecular Testing for Gastrointestinal Cancer. Journal of Pathology and Translational Medicine. 51(2). 103–121. 51 indexed citations
20.
Nam, Soo Kyung, Sumi Yun, Jiwon Koh, et al.. (2016). BRAF, PIK3CA, and HER2 Oncogenic Alterations According to KRAS Mutation Status in Advanced Colorectal Cancers with Distant Metastasis. PLoS ONE. 11(3). e0151865–e0151865. 47 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Albiruni Ryan Abdul Razak Breakdown of academic impact, for papers by Chan-Young Ock Breakdown of academic impact, for papers by Ji‐Young Choe Breakdown of academic impact, for papers by Maria Raffaella Ambrosio Breakdown of academic impact, for papers by Judith Raimbourg Breakdown of academic impact, for papers by Federico Buffoli Breakdown of academic impact, for papers by Takamitsu Kanazawa Breakdown of academic impact, for papers by Roman Groisberg Breakdown of academic impact, for papers by Xinyu Bi
Rankless by CCL
2026